Public Commitment, Not Reassurances, Needed On Indian IP: Industry
This article was originally published in PharmAsia News
Executive Summary
The Indian government has “privately reassured” drug companies it will not use compulsory licenses to override patents for commercial ends but the industry says it would like the administration to publicly “repudiate” such measures to spur investor confidence and innovation.